Amyloid-ß-directed immunotherapy for Alzheimer's disease

Lannfelt L, Relkin NR, Siemers ER (Uppsala University, Uppsala, Sweden; Weill Cornell Medical College, New York, NY; and Eli Lilly and Co., Indianapolis, IN, USA). Amyloid-ß-directed immunotherapy for Alzheimer’s disease. (Key Symposium). J Intern Med 2014; 275: 284–295. Current treatment options fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Intern Med
Autors principals: Lannfelt, L, Relkin, N R, Siemers, E R
Format: Artigo
Idioma:Inglês
Publicat: BlackWell Publishing Ltd 2014
Matèries:
Key Symposium: Updating Alzheimer's Disease Diagnosis - Implications for Prevention and Treatment
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4238820/
https://ncbi.nlm.nih.gov/pubmed/24605809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/joim.12168
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars